Am. J. Respir. Cell Mol. Biol., Volume 18, Number 5, May, 1998 611-619

Increased Endothelin-1 and Its Localization during the Development of Bleomycin-induced Pulmonary Fibrosis in Rats

Steven E. Mutsaers, Martyn L. Foster, Rachel C. Chambers, Geoffrey J. Laurent, and Robin J. McAnulty

Centre for Cardiopulmonary Biochemistry and Respiratory Medicine, University College London Medical School, Rayne Institute, London; and Dagenham Research Centre, Rhone-Poulenc Rorer, Dagenham, Essex, United Kingdom

Endothelin-1 (Et-1) has been implicated in the pathogenesis of pulmonary fibrosis with increased levels in the lung tissue of patients with pulmonary fibrosis and profibrotic effects in vitro. In this study we have investigated the temporal changes in lung Et-1 levels and immunohistochemical localization in relation to collagen deposition during the development of bleomycin-induced pulmonary fibrosis in rats. Lung Et-1 content doubled by 3 d following the intratracheal instillation of bleomycin, and continued to increase up to 7 d when values were about threefold greater than controls. Thereafter, the values for bleomycin-treated animals remained constant up to 21 d. There was no change in collagen content at 3 d but after 7 d there was a 25% increase and by 21 d levels were almost double those of the controls. In normal lung, Et-1 was predominantly associated with epithelial cells of conducting and nonconducting airways. Following bleomycin administration, intense staining of macrophages and conducting airway and alveolar epithelial cells was observed with marked staining of perivascular, peribronchiolar, and alveolar septal connective tissue, as well as the venular and arterial intima and media. These results demonstrate elevation of Et-1 levels prior to an increase in collagen content which, along with its localization within developing fibrotic lesions, provides further evidence of a profibrotic role for Et-1 in the pathogenesis of pulmonary fibrosis.

This article has been cited by other articles:

				R. Jain, P. W. Shaul, Z. Borok, and B. C. Willis Endothelin-1 Induces Alveolar Epithelial-Mesenchymal Transition through Endothelin Type A Receptor-Mediated Production of TGF-beta1 Am. J. Respir. Cell Mol. Biol., July 1, 2007; 37(1): 38 - 47. [Abstract] [Full Text] [PDF]

				A. Gunther, B. Enke, P. Markart, P. Hammerl, H. Morr, J. Behr, G. Stahler, W. Seeger, F. Grimminger, I. Leconte, et al. Safety and tolerability of bosentan in idiopathic pulmonary fibrosis: an open label study Eur. Respir. J., April 1, 2007; 29(4): 713 - 719. [Abstract] [Full Text] [PDF]

				D. C.J. Howell, R. H. Johns, J. A. Lasky, B. Shan, C. J. Scotton, G. J. Laurent, and R. C. Chambers Absence of Proteinase-Activated Receptor-1 Signaling Affords Protection from Bleomycin-Induced Lung Inflammation and Fibrosis Am. J. Pathol., May 1, 2005; 166(5): 1353 - 1365. [Abstract] [Full Text] [PDF]

				R. J. Hodges, R. G. Jenkins, C. P.D. Wheeler-Jones, D. M. Copeman, S. E. Bottoms, G. J. Bellingan, C. B. Nanthakumar, G. J. Laurent, S. L. Hart, M. L. Foster, et al. Severity of Lung Injury in Cyclooxygenase-2-Deficient Mice Is Dependent on Reduced Prostaglandin E2 Production Am. J. Pathol., November 1, 2004; 165(5): 1663 - 1676. [Abstract] [Full Text] [PDF]

				W A Dik, R J McAnulty, M A Versnel, B A E Naber, L J I Zimmermann, G J Laurent, and S E Mutsaers Short course dexamethasone treatment following injury inhibits bleomycin induced fibrosis in rats Thorax, September 1, 2003; 58(9): 765 - 771. [Abstract] [Full Text] [PDF]

				R. C. Chambers, P. Leoni, N. Kaminski, G. J. Laurent, and R. A. Heller Global Expression Profiling of Fibroblast Responses to Transforming Growth Factor-{beta}1 Reveals the Induction of Inhibitor of Differentiation-1 and Provides Evidence of Smooth Muscle Cell Phenotypic Switching Am. J. Pathol., February 1, 2003; 162(2): 533 - 546. [Abstract] [Full Text] [PDF]

				M. Fujita, R. J. Mason, C. Cool, J. M. Shannon, N. Hara, and K. A. Fagan Pulmonary hypertension in TNF-alpha -overexpressing mice is associated with decreased VEGF gene expression J Appl Physiol, December 1, 2002; 93(6): 2162 - 2170. [Abstract] [Full Text] [PDF]

				N.R. Simler, D.C.J. Howell, R.P. Marshall, N.R. Goldsack, P.S. Hasleton, G.J. Laurent, R.C. Chambers, and J.J. Egan The rapamycin analogue SDZ RAD attenuates bleomycin-induced pulmonary fibrosis in rats Eur. Respir. J., June 1, 2002; 19(6): 1124 - 1127. [Abstract] [Full Text] [PDF]

				D. C. J. Howell, N. R. Goldsack, R. P. Marshall, R. J. McAnulty, R. Starke, G. Purdy, G. J. Laurent, and R. C. Chambers Direct Thrombin Inhibition Reduces Lung Collagen, Accumulation, and Connective Tissue Growth Factor mRNA Levels in Bleomycin-Induced Pulmonary Fibrosis Am. J. Pathol., October 1, 2001; 159(4): 1383 - 1395. [Abstract] [Full Text]

				T. J. Gross and G. W. Hunninghake Idiopathic Pulmonary Fibrosis N. Engl. J. Med., August 16, 2001; 345(7): 517 - 525. [Full Text] [PDF]

				H. Saito, H. Nakamura, S. Kato, S. Inoue, M. Inage, M. Ito, and H. Tomoike Percutaneous in vivo gene transfer to the peripheral lungs using plasmid-liposome complexes Am J Physiol Lung Cell Mol Physiol, October 1, 2000; 279(4): L651 - L657. [Abstract] [Full Text] [PDF]

				P. Teder and P. W. Noble A Cytokine Reborn? . Endothelin-1 in Pulmonary Inflammation and Fibrosis Am. J. Respir. Cell Mol. Biol., July 1, 2000; 23(1): 7 - 10. [Full Text]

				B. Hocher, A. Schwarz, K. A. Fagan, C. Thöne-Reineke, K. El-Hag, H. Kusserow, S. Elitok, C. Bauer, H.-H. Neumayer, D. M. Rodman, et al. Pulmonary Fibrosis and Chronic Lung Inflammation in ET-1 Transgenic Mice Am. J. Respir. Cell Mol. Biol., July 1, 2000; 23(1): 19 - 26. [Abstract] [Full Text]

				R. M. Day, Y. j. Suzuki, J. M. Lum, A. C. White, and B. L. Fanburg Bleomycin upregulates expression of gamma -glutamylcysteine synthetase in pulmonary artery endothelial cells Am J Physiol Lung Cell Mol Physiol, June 1, 2002; 282(6): L1349 - L1357. [Abstract] [Full Text] [PDF]